Results 171 to 180 of about 5,445 (182)

Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites

Hepatology Research, 2017
Tomomi Kogiso, Makiko Taniai
exaly  

Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery

General Thoracic and Cardiovascular Surgery, 2016
Takashi Kido, Masayuki Sakaki, Toshiki Takahashi   +2 more
exaly  

Predictive parameter of tolvaptan effectiveness in cirrhotic ascites

Hepatology Research, 2017
Hideto Kawaratani, Hiroshi Fukui, Kei Moriya   +2 more
exaly  

Effects of Tolvaptan on Volume Overload in Japanese Patients with Heart Failure: Results of a Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study

Cardiovascular Drugs and Therapy, 2011
Hidetsugu Asanoi, Takayoshi Tsutamoto, Matsuzaki Masunori   +2 more
exaly  

Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions

Journal of Clinical Medicine, 2014
Kirkwood Adams, J Herbert Patterson, Kirkwood F Adams   +2 more
exaly  

Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion

Hypertension Research, 2018
Yoshihiro Seo, Tomoko Ishizu
exaly  

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan

Journal of Gastroenterology, 2015
Hidetsugu Tsubouchi, Sakaida Isao, Okita Kiwamu   +2 more
exaly  

Tolvaptan

Reactions Weekly, 2013
openaire   +2 more sources

Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects

European Journal of Clinical Pharmacology, 2011
Susan E Shoaf, Suresh Mallikaarjun, Patricia Bricmont   +2 more
exaly  

Tolvaptan Administration Does Not Affect Steady State Amiodarone Concentrations in Patients With Cardiac Arrhythmias

Journal of Cardiovascular Pharmacology and Therapeutics, 2005
Jorge Lerman, Cesare Orlandi
exaly